在各市场之间对比单一化妆品物质
输入一个 INCI 名称、化学名称、CAS 或 EC 编号。该工具将欧盟附件证据、关联的成分身份和独立的官方国家记录合并为一份对比。
缺少本地记录会显示为证据缺口,绝不视为准许或安全性结论。
搜索确切身份
对比查询
HYDROGENATED PEANUT OIL
在 13 个市场数据集中的 4 个找到了匹配的监管证据。
有证据的市场
4
证据缺口
9
国家记录
3
欧盟附件记录
1
已解析的身份证据
CAS:68425-36-58002-03-791744-77-368440-49-393572-05-561789-56-861789-57-973138-79-191051-35-3
EC:270-350-9232-296-4293-087-1294-643-6297-433-2263-069-8263-070-3277-298-6
6 个匹配或报告的名称
HYDROGENATED PEANUT OILARACHIS HYPOGAEA OIL; ARACHIS HYPOGAEA SEEDCOAT EXTRACT; ARACHIS HYPOGAEA FLOUR; ARACHIS HYPOGAEA FRUIT EXTRACT; ARACHIS HYPOGAEA SPROUT EXTRACT; HYDROGENATED PEANUT OIL; PEANUT ACID; PEANUT GLYCERIDES; PEANUT OIL PEG-6 ESTERS; PEANUTAMIDE MEA; PEANUTAMIDE MIPA; POTASSIUM PEANUTATE; SODIUM PEANUTAMPHOACETATE; SODIUM PEANUTATE; SULFATED PEANUT OILPeanut oil, extracts and derivativesPeanut oil, extracts and derivatives e.g. Hydrogenated peanut oilPeanut oil extracts and derivatives Arachis Hypogaea Oil Arachis Hypogaea Seedcoat Extract Arachis Hypogaea Flour Arachis Hypogaea Fruit Extract Arachis Hypogaea Sprout Extract Hydrogenated Peanut Oil Peanut Acid Peanut Glycerides Peanut Oil PEG-6 Esters Peanutamide MEA Peanutamide MIPA Potassium Peanutate Sodium Peanutamphoacetate Sodium Peanutate Sulfated Peanut Oil CAS Nos 8002-03-7/8002-03-7/8002-03-7 8002-03-7/68425-36-5 91051-35-3/91744-77-3 68440-49-3/93572-05-5 61789-56-8/61789-57-9/73138-79-1Peanut oil, extracts and derivatives Arachis Hypogaea Oil, Arachis Hypogaea Seedcoat Extract, Arachis Hypogaea Flour, Arachis Hypogaea Fruit Extract (8002-03-7) ARACHIS HYPOGAEA SPROUT EXTRACT. Hydrogenated Peanut Oil (68425-36-5) Peanut Acid (91051-35-3) Peanut Glycerides (91744-77-3) Peanut Oil PEG-6 Esters (68440-49-3) Peanutamide MEA (93572-05-5) Peanutamide MIPA Potassium Peanutate (61789-56-8) Sodium Peanutamphoacetate Sodium Peanutate (61789-57-9) Sulfated Peanut Oil (73138-79-1)
按市场划分的监管证据
状态为我们数据集中最强的匹配记录。请打开记录查看确切条件和法律范围。
| 市场 | 结果 | 记录 | 数据集覆盖范围 | 后续操作 |
|---|---|---|---|---|
| European Union EU | 限用 | 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | 请查看每条匹配记录及其条件。 |
| Great Britain GB | 未找到匹配项 | 0 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework. |
| Canada CA | 未找到匹配项 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Restricted | 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | 请查看每条匹配记录及其条件。 |
| ASEAN ASEAN | Restricted | 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | 请查看每条匹配记录及其条件。 |
| China CN | 未找到匹配项 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | 未找到匹配项 | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | 未找到匹配项 | 0 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Korean source wording is canonical and other positive lists/notices may still apply to the formulation. |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | 未找到匹配项 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | Restricted | 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | 请查看每条匹配记录及其条件。 |
| Saudi Arabia SA | 未找到匹配项 | 0 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply. |
没有与此筛选条件匹配的市场行。
匹配的记录和条件
New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)完成官方核实工作流程
成分证据只是其中一层。这些针对特定市场的步骤列出了作出合规决定之前仍需完成的核查。
European Union · Complete annex dataset
- Confirm the exact INCI/CAS/EC identity.
- Review every matching Annex II–VI row and its conditions.
- Check SCCS opinions, CMR/nanomaterial rules and later amendments.
- Verify product classification, claims, labelling and responsible-person duties.
Great Britain · Complete consolidated annex dataset
- Confirm INCI/CAS/EC identity.
- Review every current GB Annex II–VI match.
- Check commencement dates and later statutory instruments.
- Verify SCPN, responsible-person, safety-report and labelling duties.
Canada · Complete Hotlist snapshot
- Search English/French names and CAS identifiers.
- Apply every restriction, concentration and label warning.
- Check Food and Drugs Act/Cosmetic Regulations requirements.
- Recheck the current Hotlist before notification or sale.
New Zealand · Complete schedules dataset
- Search exact identity across Schedules 4–8.
- Apply use, concentration and warning conditions.
- Check hazardous-substance classification and Group Standard scope.
- Confirm the latest legal instrument, not only the spreadsheet.
ASEAN · Complete regional annex dataset
- Search all ACD annexes by name and identifiers.
- Apply product type, maximum level and warning conditions.
- Confirm the target member state's adoption and transition date.
- Complete the local notification and responsible-company requirements.
China · Complete prohibited catalogues plus official-source workflow
- Search the current NMPA IECIC List I and List II by Chinese name and identity.
- Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
- Review technical purpose, use history and any monitoring period.
- Confirm Chinese labelling, safety assessment and filing/registration duties.
Japan · Complete Standards appendices dataset
- Search Japanese/English identity and CAS where present.
- Apply category and maximum-amount conditions.
- Check later MHLW notices against the Japanese source.
- Verify marketing licence, notification, labelling and quasi-drug classification.
South Korea · Complete current appendix dataset
- Match the Korean canonical substance name and identifiers.
- Review all Appendix 1 and 2 matches and conditions.
- Check functional-cosmetic and positive-list requirements where applicable.
- Confirm current MFDS notice, responsible seller and label obligations.
United States · Complete enumerated federal ingredient rules
- Search Part 700 and all relevant colour-additive parts.
- Confirm colour additive identity, permitted uses, limits and certification status.
- Assess safety and adulteration under the FD&C Act.
- Complete MoCRA facility/product, adverse-event and label obligations where applicable.
Australia · Complete cosmetic-relevant Poisons Standard subset plus official workflow
- Decide whether the product is a cosmetic or therapeutic good.
- Check the current Poisons Standard for every ingredient.
- Search AICIS Inventory terms and assessment certificates by exact identity.
- Determine introduction category, registration, reporting, records and labelling duties.
Brazil · Complete prohibited dataset plus current restricted-list workflow
- Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
- Check the consolidated prohibited list including RDC 1.030/2026 changes.
- Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
- Verify Mercosur incorporation, regularisation, labelling and transition periods.
India · Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
- Confirm product class and current Cosmetics Rules/gazette amendments.
- Check all applicable parts of IS 4707 by exact identity.
- Apply Schedule S/other finished-product standards where relevant.
- Verify licence/import registration, labelling and testing requirements.
Saudi Arabia · Complete official list index
- Search names and CAS across both SFDA lists.
- Open the cited restricted-entry detail and apply every condition.
- Check current SFDA/GSO technical regulations and updates.
- Complete eCosma notification, label and responsible-party requirements.
本对比能够和不能决定什么
1. 解析身份
CAS 和 EC 标记会被精确提取。名称搜索使用规范化的官方名称和关联的身份。
2. 对比证据
针对每个受支持的市场,分别显示最强的匹配状态和直接记录。
3. 完成核实
产品类型、浓度、纯度、警示语、宣称、分类及后续修订仍需官方审核。